135 related articles for article (PubMed ID: 37119273)
21. Comment on "Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study".
Niculet E; Tatu AL
J Am Acad Dermatol; 2022 Jul; 87(1):e49-e50. PubMed ID: 35398379
[No Abstract] [Full Text] [Related]
22. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
[TBL] [Abstract][Full Text] [Related]
23. [The Muffin technique--an alternative to Mohs' micrographic surgery].
Möhrle M; Breuninger H
J Dtsch Dermatol Ges; 2006 Dec; 4(12):1080-4. PubMed ID: 17176417
[No Abstract] [Full Text] [Related]
24. Histopathologic pitfalls of Mohs micrographic surgery and a review of tumor histology.
França K; Alqubaisy Y; Hassanein A; Nouri K; Lotti T
Wien Med Wochenschr; 2018 Jun; 168(9-10):218-227. PubMed ID: 27832425
[TBL] [Abstract][Full Text] [Related]
25. Punch biopsy: one more possible stage in Mohs micrographic surgery.
Camps-Fresneda A; Ocampo J; Torné R
J Dermatol Surg Oncol; 1993 Feb; 19(2):171. PubMed ID: 8429146
[No Abstract] [Full Text] [Related]
26. Is curettage really necessary for basal cell carcinoma before Mohs micrographic surgery?
Kimyai-Asadi A; Jih MH; Goldberg LH
Dermatol Surg; 2004 May; 30(5):820; author reply 821-2. PubMed ID: 15099334
[No Abstract] [Full Text] [Related]
27. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
[TBL] [Abstract][Full Text] [Related]
28. The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital.
Takata Pontes L; Fantelli Stelini R; Cintra ML; Magalhães RF; Velho PE; Moraes AM
Clinics (Sao Paulo); 2015 Nov; 70(11):721-5. PubMed ID: 26602517
[TBL] [Abstract][Full Text] [Related]
29. Reasons for Mohs Micrographic Surgery Cancellation: A Retrospective 1-Year Analysis in a Tertiary Care Clinic Before the COVID-19 Pandemic.
Nadimi AE; Spierling Bagsic SR; Prosser M; Greenway HT
Dermatol Surg; 2022 Feb; 48(2):252-253. PubMed ID: 34889216
[No Abstract] [Full Text] [Related]
30. Reply to "Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study".
Lim GFS; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2023 Feb; 88(2):e95-e96. PubMed ID: 35995092
[No Abstract] [Full Text] [Related]
31. Characteristics of non-melanoma skin cancers in Native American patients treated with Mohs micrographic surgery.
Tchanque-Fossuo CN; Ravichandran N; Barbosa NS
Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259853
[TBL] [Abstract][Full Text] [Related]
32. Histopathological discrepancy between biopsy and Mohs micrographic surgery in keratinocyte carcinoma: A 464 case series in an Australian population.
Stewart N; Rodríguez Bandera AI; Lee S
Australas J Dermatol; 2021 Feb; 62(1):41-46. PubMed ID: 32808286
[TBL] [Abstract][Full Text] [Related]
33. Mohs micrographic surgery for facial skin cancer.
Jones NS
Arch Facial Plast Surg; 2002; 4(2):125. PubMed ID: 12020214
[No Abstract] [Full Text] [Related]
34. Characterizing basal cell carcinoma in Hispanic individuals undergoing Mohs micrographic surgery: a 7-year retrospective review at an academic institution in the Bronx.
Soliman YS; Mieczkowska K; Zhu TR; Hossain O; Zhu TH; Ciocon DH; Williams RF
Br J Dermatol; 2022 Oct; 187(4):597-599. PubMed ID: 35442518
[No Abstract] [Full Text] [Related]
35. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
[TBL] [Abstract][Full Text] [Related]
36. Mohs micrographic surgery.
Rush E
J Vis Commun Med; 2009 Jun; 32(2):49-52. PubMed ID: 20014967
[No Abstract] [Full Text] [Related]
37. Dermoscopy prior to Mohs micrographic surgery does not improve tumour margin assessment and leads to fewer Mohs stages.
Jayasekera PSA; Dodd J; Oliphant T; Langtry JAA; Lawrence CM
Br J Dermatol; 2018 Feb; 178(2):565-566. PubMed ID: 28851098
[No Abstract] [Full Text] [Related]
38. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
Moehrle M; Breuninger H; Schippert W; Häfner HM
Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
[No Abstract] [Full Text] [Related]
39. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
40. Penile basal cell carcinoma: two cases treated with Mohs micrographic surgery and remarks on pathogenesis.
Nguyen H; Saadat P; Bennett RG
Dermatol Surg; 2006 Jan; 32(1):135-44. PubMed ID: 16393615
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
